PHE_Scientific_Development of an Ovine Polyclonal Immunoglobulin Therapy.
This requirement was to develop a rapid and effective therapy against infection by developing an ovine immunoglobulin treatment against the spike protein of Covid 19. Additional information: PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak for the research of therapeutic antibodies.
Buyer
Public Health England
Value
£26,523
Published
9 Feb 2021
Closes
16 Apr 2020
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Goods
Contract starts
16 Apr 2020
Contract ends
16 Apr 2021
CPV classifications
24956000
Peptones and protein substances
Lots
Lot default PHE_Scientific_Development of an Ovine Polyclonal Immunoglobulin Therapy.
£26,523
This requirement was to develop a rapid and effective therapy against infection by developing an ovine immunoglobulin treatment against the spike protein of Covid 19. Additional information: PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (C...
Delivery: South West · United Kingdom, South West, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
9 Feb 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.